(-)-Epigallocatechin-3-Gallate (EGCG) Maintains κ-Casein in Its Pre-Fibrillar State without Redirecting Its Aggregation Pathway

Journal of Molecular Biology

Volumn 392, Issue 3, 2009, Pages 689-700

  Hudson, Sean A ^a   Ecroyd, Heath ^a   Dehle, Francis C ^a   Musgrave, Ian F ^a   Carver, John A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

( ) epigallocatechin 3 gallate; amyloid fibril; EGCG; polyphenol; casein

Indexed keywords

AMYLOID; EPIGALLOCATECHIN GALLATE; KAPPA CASEIN; POLYPEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG TARGETING; FIBER; HYDROPHOBICITY; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS INHIBITION; RAT;

AMYLOID; ANIMALS; CASEINS; CATECHIN; CIRCULAR DICHROISM; HUMANS; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 69349098271     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.07.031     Document Type: Article

References (65)

1. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
2. Ecroyd H., and Carver J.A. Unraveling the mysteries of protein folding and misfolding. IUBMB Life 60 (2008) 769-774
3. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S., et al. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 12 (2005) 1-4
4. Sacchettini J.C., and Kelly J.W. Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Discov. 1 (2002) 267-275
5. Rochet J.C. Novel therapeutic strategies for the treatment of protein-misfolding diseases. Expert Rev. Mol. Med. 9 (2007) 1-34
6. Chaudhuri T.K., and Paul S. Protein-misfolding diseases and chaperone-based therapeutic approaches. FEBS J. 273 (2006) 1331-1349
7. Sciarretta K.L., Gordon D.J., and Meredith S.C. Peptide-based inhibitors of amyloid assembly. Methods Enzymol. 413 (2006) 273-312
8. Porat Y., Abramowitz A., and Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 67 (2006) 27-37
9. Yamin G., Ono K., Inayathullah M., and Teplow D.B. Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease. Curr. Pharm. Des. 14 (2008) 3231-3246
10. Ono K., Hirohata M., and Yamada M. Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders. Curr. Pharm. Des. 14 (2008) 3247-3266
11. Barten D.M., and Albright C.F. Therapeutic strategies for Alzheimer's disease. Mol. Neurobiol. 37 (2008) 171-186
12. Dobson C.M. Protein aggregation and its consequences for human disease. Prot. Peptide Lett. 13 (2006) 219-227
13. Riviere C., Richard T., Quentin L., Krisa S., Merillon J.M., and Monti J.P. Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro. Bioorg. Med. Chem. 15 (2007) 1160-1167
14. Kim H., Park B.S., Lee K.G., Choi C.Y., Jang S.S., Kim Y.H., and Lee S.E. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J. Agric. Food Chem. 53 (2005) 8537-8541
15. Chen D., Milacic V., Chen M.S., Wan S.B., Lam W.H., Huo C., et al. Tea polyphenols, their biological effects and potential molecular targets. Histol. Histopathol. 23 (2008) 487-496
16. Basu A., and Lucas E.A. Mechanisms and effects of green tea on cardiovascular health. Nutr. Rev. 65 (2007) 361-375
17. Moon H.S., Lee H.G., Choi Y.J., Kim T.G., and Cho C.S. Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem.-Biol. Interact. 167 (2007) 85-98
18. Tipoe G.L., Leung T.M., Hung M.W., and Fung M.L. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc. Hematol. Disord. Drug Targets 7 (2007) 135-144
19. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr. 26 (2007) 373S-388S
20. Babu P.V., and Liu D. Green tea catechins and cardiovascular health: an update. Curr. Med. Chem. 15 (2008) 1840-1850
21. Khan N., and Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 269 (2008) 269-280
22. Kim J.A. Mechanisms underlying beneficial health effects of tea catechins to improve insulin resistance and endothelial dysfunction. Endocr. Metab. Immune Disord. Drug Targets 8 (2008) 82-88
23. Yang C.S., Ju J., Lu G., Xiao H., Hao X., Sang S., and Lambert J.D. Cancer prevention by tea and tea polyphenols. Asia Pac. J. Clin. Nutr. 17 Suppl. 1 (2008) 245-248
24. Yang C.S., Lambert J.D., and Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch. Toxicol. 83 (2009) 11-21
25. Ono K., Condron M.M., Ho L., Wang J., Zhao W., Pasinetti G.M., and Teplow D.B. Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J. Biol. Chem. 283 (2008) 32176-32187
26. Rezai-Zadeh K., Arendash G.W., Hou H., Fernandez F., Jensen M., Runfeldt M., et al. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 1214 (2008) 177-187
27. Rasoolijazi H., Joghataie M.T., Roghani M., and Nobakht M. The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis. Iran. Biomed. J. 11 (2007) 237-243
28. Lin C.L., Chen T.F., Chiu M.J., Way T.D., and Lin J.K. Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation. Neurobiol. Aging 30 (2009) 81-92
29. Shimmyo Y., Kihara T., Akaike A., Niidome T., and Sugimoto H. Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. NeuroReport 19 (2008) 1329-1333
30. Mandel S.A., Amit T., Kalfon L., Reznichenko L., Weinreb O., and Youdim M.B. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J. Alzheimer's Dis. 15 (2008) 211-222
31. Avramovich-Tirosh Y., Reznichenko L., Mit T., Zheng H., Fridkin M., Weinreb O., et al. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG. Curr. Alzheimer Res. 4 (2007) 403-411
32. Choi Y.T., Jung C.H., Lee S.R., Bae J.H., Baek W.K., Suh M.H., et al. The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci. 70 (2001) 603-614
33. Reznichenko L., Amit T., Zheng H., Avramovich-Tirosh Y., Youdim M.B., Weinreb O., and Mandel S. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease. J. Neurochem. 97 (2006) 527-536
34. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., Lurz R., et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15 (2008) 558-566
35. Ehrnhoefer D.E., Duennwald M., Markovic P., Wacker J.L., Engemann S., Roark M., et al. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum. Mol. Genet. 15 (2006) 2743-2751
36. Ecroyd H., Koudelka T., Thorn D.C., Williams D.M., Devlin G., Hoffmann P., and Carver J.A. Dissociation from the oligomeric state is the rate-limiting step in fibril formation by kappa-casein. J. Biol. Chem. 283 (2008) 9012-9022
37. Thorn D.C., Meehan S., Sunde M., Rekas A., Gras S.L., MacPhee C.E., et al. Amyloid fibril formation by bovine milk kappa-casein and its inhibition by the molecular chaperones alphaS- and beta-casein. Biochemistry 44 (2005) 17027-17036
38. Vreeman H.J., Brinkhuis J.A., and van der Spek C.A. Some association properties of bovine SH-kappa-casein. Biophys. Chem. 14 (1981) 185-193
39. Kumosinski T.F., Brown E.M., and Farrell Jr. H.M. Three-dimensional molecular modeling of bovine caseins: a refined, energy-minimized kappa-casein structure. J. Dairy Sci. 76 (1993) 2507-2520
40. Farrell Jr. H.M., Cooke P.H., Wickham E.D., Piotrowski E.G., and Hoagland P.D. Environmental influences on bovine kappa-casein: reduction and conversion to fibrillar (amyloid) structures. J. Protein Chem. 22 (2003) 259-273
41. Schmitz K.S. Dynamic Light Scattering By Macromolecules (1990), Academic Press, Boston, MA
42. Paz M.A., Fluckiger R., Boak A., Kagan H.M., and Gallop P.M. Specific detection of quinoproteins by redox-cycling staining. J. Biol. Chem. 266 (1991) 689-692
43. Gutierrez P.L. The metabolism of quinone-containing alkylating agents: free radical production and measurement. Front. Biosci. 5 (2000) D629-D638
44. Marini I., Moschini R., Corso A.D., and Mura U. Chaperone-like features of bovine serum albumin: a comparison with alpha-crystallin. Cell. Mol. Life Sci. 62 (2005) 3092-3099
45. Zunszain P.A., Ghuman J., Komatsu T., Tsuchida E., and Curry S. Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct. Biol. 3 (2003) 6
46. Huo C., Wan S.B., Lam W.H., Li L., Wang Z., Landis-Piwowar K.R., et al. The challenge of developing green tea polyphenols as therapeutic agents. Inflammopharmacology 16 (2008) 248-252
47. Kajiya K., Kumazawa S., Naito A., and Nakayama T. Solid-state NMR analysis of the orientation and dynamics of epigallocatechin gallate, a green tea polyphenol, incorporated into lipid bilayers. Magn. Reson. Chem. 46 (2008) 174-177
48. Feng B.Y., Toyama B.H., Wille H., Colby D.W., Collins S.R., May B.C., et al. Small-molecule aggregates inhibit amyloid polymerization. Nat. Chem. Biol. 4 (2008) 197-199
49. Weber K., and Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Biol. Chem. 244 (1969) 4406-4412
50. Meehan S., Knowles T.P., Baldwin A.J., Smith J.F., Squires A.M., Clements P., et al. Characterisation of amyloid fibril formation by small heat-shock chaperone proteins human alphaA-, alphaB- and R120G alphaB-crystallins. J. Mol. Biol. 372 (2007) 470-484
51. Rekas A., Adda C.G., Andrew Aquilina J., Barnham K.J., Sunde M., Galatis D., et al. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity. J. Mol. Biol. 340 (2004) 1167-1183
52. Ecroyd H., and Carver J.A. Crystallin proteins and amyloid fibrils. Cell. Mol. Life Sci. 66 (2009) 62-81
53. Gazit E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J. 16 (2002) 77-83
54. Gazit E. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool. FEBS J. 272 (2005) 5971-5978
55. Shoval H., Lichtenberg D., and Gazit E. The molecular mechanisms of the anti-amyloid effects of phenols. Amyloid 14 (2007) 73-87
56. Soto C., and Estrada L.D. Protein misfolding and neurodegeneration. Arch. Neurol. 65 (2008) 184-189
57. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81 (2003) 678-699
58. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14 (2008) 837-842
59. Shechter Y., Patchornik A., and Burstein Y. Selective reduction of cystine I-VIII in alpha-lactalbumin of bovine milk. Biochemistry 12 (1973) 3407-3413
60. Fox P.F., and McSweeney P.L.H. Dairy Chemistry and Biochemistry (1998), Blackie Academic & Professional, London, UK
61. Peters Jr. T. All About Albumin: Biochemistry, Genetics, and Medical Applications (1995), Academic Press Inc., San Diego, CA
62. Provencher S.W. CONTIN: a general purpose constrained regularization program for inverting noisy linear algebraic and integral equations. Comput. Phys. Commun. 27 (1982) 229-242
63. Koppel D.E. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J. Chem. Phys. 57 (1972) 4814-4820
64. Yerbury J.J., Poon S., Meehan S., Thompson B., Kumita J.R., Dobson C.M., and Wilson M.R. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 21 (2007) 2312-2322
65. Maiti T.K., Ghosh K.S., and Dasgupta S. Interaction of (-)-epigallocatechin-3-gallate with human serum albumin: fluorescence, Fourier transform infrared, circular dichroism, and docking studies. Proteins 64 (2006) 355-362